Clinical Trial Update: OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

View source ↗

Summary

OpalGenix, Inc. is recruiting adults for a clinical trial of personalized postoperative pain management after lumbar spinal fusion and decompression surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease
• Lumbar Spinal Stenosis

Drugs mentioned

• OpalGenix

Snippet

Sponsor: OpalGenix, Inc | Conditions: Lumbar Spine Stenosis, Lumbar Spine Degeneration | Status: RECRUITING